Valor Iv Pharma Holdings, Llc - Net Worth and Insider Trading

Valor Iv Pharma Holdings, Llc Net Worth

The estimated net worth of Valor Iv Pharma Holdings, Llc is at least $226 Million dollars as of 2024-12-27. Valor Iv Pharma Holdings, Llc is the 10% Owner of Harmony Biosciences Holdings Inc and owns about 6,618,033 shares of Harmony Biosciences Holdings Inc (HRMY) stock worth over $226 Million. Details can be seen in Valor Iv Pharma Holdings, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Valor Iv Pharma Holdings, Llc has not made any transactions after 2024-11-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Valor Iv Pharma Holdings, Llc

Valor Iv Pharma Holdings, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Valor Iv Pharma Holdings, Llc owns 1 companies in total, including Harmony Biosciences Holdings Inc (HRMY) .

Click here to see the complete history of Valor Iv Pharma Holdings, Llc’s form 4 insider trades.

Insider Ownership Summary of Valor Iv Pharma Holdings, Llc

Ticker	Comapny	Transaction Date	Type of Owner
HRMY	Harmony Biosciences Holdings Inc	2024-11-05	10 percent owner

Valor Iv Pharma Holdings, Llc Latest Holdings Summary

Valor Iv Pharma Holdings, Llc currently owns a total of 1 stock. Valor Iv Pharma Holdings, Llc owns 6,618,033 shares of Harmony Biosciences Holdings Inc (HRMY) as of November 5, 2024, with a value of $226 Million.

Latest Holdings of Valor Iv Pharma Holdings, Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HRMY	Harmony Biosciences Holdings Inc	2024-11-05	6,618,033	34.20	226,336,729

Holding Weightings of Valor Iv Pharma Holdings, Llc

Valor Iv Pharma Holdings, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Valor Iv Pharma Holdings, Llc has made a total of 1 transactions in Harmony Biosciences Holdings Inc (HRMY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Harmony Biosciences Holdings Inc is the sale of 4,600,000 shares on November 5, 2024, which brought Valor Iv Pharma Holdings, Llc around $139 Million.

Insider Trading History of Valor Iv Pharma Holdings, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Valor Iv Pharma Holdings, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Valor Iv Pharma Holdings, Llc Ownership Network

Ownership Network List of Valor Iv Pharma Holdings, Llc

No Data

Ownership Network Relation of Valor Iv Pharma Holdings, Llc

Valor Iv Pharma Holdings, Llc Owned Company Details

What does Harmony Biosciences Holdings Inc do?

Who are the key executives at Harmony Biosciences Holdings Inc?

Valor Iv Pharma Holdings, Llc is the 10 percent owner of Harmony Biosciences Holdings Inc. Other key executives at Harmony Biosciences Holdings Inc include 10 percent owner Marshman Fund Trust Ii , Chief Commercial Officer Jeffrey Dierks , and Chief Business Officer Andrew Serafin .

Harmony Biosciences Holdings Inc (HRMY) Insider Trades Summary

Over the past 18 months, Valor Iv Pharma Holdings, Llc made 1 insider transaction in Harmony Biosciences Holdings Inc (HRMY) with a net sale of 4,600,000. Other recent insider transactions involving Harmony Biosciences Holdings Inc (HRMY) include a net sale of 106,072 shares made by Jeffrey Dierks , a net sale of 4,600,000 shares made by Marshman Fund Trust Ii ,

In summary, during the past 3 months, insiders sold 9,293,699 shares of Harmony Biosciences Holdings Inc (HRMY) in total and bought 0 shares, with a net sale of 9,293,699 shares. During the past 18 months, 9,306,072 shares of Harmony Biosciences Holdings Inc (HRMY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,306,072 shares.

Harmony Biosciences Holdings Inc (HRMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Harmony Biosciences Holdings Inc Insider Transactions

No Available Data

Valor Iv Pharma Holdings, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Valor Iv Pharma Holdings, Llc. You might contact Valor Iv Pharma Holdings, Llc via mailing address: 875 N. Michigan Avenue, Suite 3214, Chicago Il 60611.

Discussions on Valor Iv Pharma Holdings, Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.